TCR based autologous cell therapy (Treadwell Therapeutics)

N/A

Report date: 2025/06/11 10:26:08

Base Information

Drug NameTCR based autologous cell therapy (Treadwell Therapeutics)
Drug Alias NameMultiple TCRs
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionImmunostimulantsT lymphocytes stimulants
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTreadwell Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesTreadwell Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A